Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Patient Educ Couns. 2016 Aug 26;100(2):190–198. doi: 10.1016/j.pec.2016.08.027

Motivational Interviewing to Improve Health Screening Uptake: A Systematic Review

Sarah J Miller a, Kelly Foran-Tuller b, Jessica Lederberger c, Lina Jandorf a
PMCID: PMC5318209  NIHMSID: NIHMS816370  PMID: 27599713

Abstract

Objective

Health screenings, physical tests that diagnose disease, are underutilized. Motivational interviewing (MI) may increase health screening rates. This paper systematically reviewed the published articles that examined the efficacy of MI for improving health screening uptake.

Methods

Articles published before April 28, 2015 were reviewed from PubMed, PsycINFO, and CINAHL. Study methodology, participant demographics, outcomes and quality were extracted from each article.

Results

Of the 1573 abstracts, 13 met inclusion criteria. Of the 13 studies, 6 found MI more efficacious than a control, 2 found MI more efficacious than a weak control yet equivalent to an active control, and 3 found MI was not significantly better than a control. Two single arm studies reported improvements in health screening rates following an MI intervention.

Conclusions

MI shows promise for improving health screening uptake. However, given the mixed results, the variability amongst the studies and the limited number of randomized trials, it is difficult to discern the exact impact of MI on health screening uptake.

Practice Implications

Future research is needed to better understand the impact of MI in this context. Such research would determine whether MI should be integrated into standard clinical practice for improving health screening uptake.

Keywords: motivational interviewing, health screenings, prevention

1. Introduction

Health screenings are clinical tests that can be used to diagnose disease, often before symptoms are present. Health screenings are important in the detection of early stage disease, and thus can aid in the prevention of both disease progression and mortality. A wide range of diseases including, diabetes, hypertension, sexually transmitted infections, and some types of cancers can be detected through the use of health screenings. Despite their importance, health screenings remain underutilized. For example, in the United States, more than one-third (35.5%) of adults aged 50–75 have not received a colorectal cancer screening within the recommended time frame (e.g., a screening colonoscopy every ten years) [1]; 64% of adults over the age of 18 have never received an HIV test [2]; and 27.6% of women aged 50–74 have not received a mammogram within a two year timeframe [3]. It is critical to implement interventions to improve the uptake of health screenings across the United States.

Motivational interviewing (MI) may help improve the uptake of health screenings. MI is defined as “a collaborative conversation style for strengthening a person’s own motivation and commitment to change.” (p.12) [4]. The intervention is client-centered and helps individuals acknowledge and resolve any ambivalence they might have to change. In the most recent edition of their book, Miller and Rollnick describe that MI involves four processes: (1) engaging the patient in order to form a strong working relationship, (2) focusing the goal or direction of the conversation, (3) evoking the patient’s own motivations for change, and (4) planning for change by increasing the patient’s commitment to change and then developing an action plan.[4] The four processes are not necessarily linear and MI interventionists often move from one process to another. Unlike unidirectional advice giving, MI practitioners use client-centered communication skills, including asking open ended questions, affirming the client’s strengths and previous successes, reflective listening, summarizing, and informing/advising [4].

MI was originally developed to treat substance use, and extensive research supports its efficacy for treating drug, alcohol, and nicotine use [58]. More recently, MI has been implemented in healthcare settings to help patients reduce risky behaviors and increase healthy behaviors. Previous systematic reviews and meta-analyses have examined MI’s efficacy for improving health behaviors. The results of those reviews and meta-analyses found that, although the literature is mixed, MI demonstrates promise in the healthcare arena and, in particular, may help improve behaviors such as diet and exercise, diabetes management, and oral health [6,915]. In fact, two meta-analyses reported that MI had significant impacts on physical outcomes (e.g., BMI reduction [16], dental outcomes, HIV viral load [17]).

To our knowledge, no systematic review has examined the efficacy of MI to improve health screening uptake. Health screenings are a key component of disease prevention and it is imperative to understand whether MI can effectively help individuals complete these important screenings. This article will systematically review the published intervention studies that examined the efficacy of MI for improving physical health screening uptake.

2. Methods

2.1 Search Strategy

Articles were reviewed from three electronic databases (PubMed, PsycINFO, and CINAHL) that were published on or before April 28, 2015. The search terms varied based on the available search words in the each electronic database. For PubMed, the search terms were (("Mass Screening"[Mesh]) AND ("Motivation"[Mesh] OR "Motivational Interviewing"[Mesh] OR "Counseling"[Mesh] OR "Intervention Studies"[Mesh])). The search was limited by language (English), methodology (case reports, clinical trial phase I-IV, comparative study, controlled clinical trial, evaluation studies, interview, randomized controlled trial, technical report), and sample (humans). Only articles that had a published abstract available were reviewed. This search yielded 448 abstracts.

For PsycINFO, the search terms were ((exp health screening) AND (exp counseling OR exp motivational interviewing OR exp intervention OR exp motivation)). This search was limited by language (English), methodology (clinical case study, empirical study, experimental replication, follow-up study, longitudinal study, prospective study, retrospective study, field study, interview, focus group, nonclinical case study, qualitative study, quantitative study, treatment outcome/clinical trial) and sample (humans). This search yielded 909 abstracts.

For CINAHL, the search terms were ((MH motivation OR MH motivational interviewing OR MH intervention OR MH counseling) and (MH health screening)). This search was limited by language (English), publication type (academic journal), and subjects (humans). Only articles that had a published abstract were reviewed. This search yielded 216 abstracts.

2.2 Selection Strategy

In total, 1573 abstracts were identified through the electronic database search. After removing duplicates, two coders independently reviewed 1476 abstracts to consensus on the following inclusion criteria: (1) implemented an MI intervention (e.g., motivational interviewing, motivational enhancement); and (2) included a health screening as an outcome of the study. Although there are screenings for mental health/behavioral health (e.g., depression screenings, substance abuse screenings), this search was limited to physical health screenings (e.g., cancer screenings, HIV test). In total, 27 abstracts met the aforementioned inclusions criteria. Next, those 27 articles were read in entirety by two independent coders to determine whether they met the inclusion criteria. An additional two articles were reviewed in entirety based on the coders’ familiarity with the first author’s research. These two articles, both published by Manne, were included in the 1476 abstracts reviewed; however, they did not discuss the incorporation of MI the abstract. After the 29 articles were read and reviewed, an additional 16 articles were excluded because they did not meet eligibility criteria (e.g., implementation studies). In total, 13 articles were included in the final systematic review. See Figure 1 for a flow diagram of the reviewed articles, in accordance with the PRISMA guidelines [18,19].

Figure 1.

Figure 1

PRISMA Flow Diagram

2.3 Data Extraction

A data extraction sheet was used to gather the following information: (1) authors and publication date; (2) participant information (i.e., sample size, race, age, gender); (3) research design (e.g., randomized controlled trial); (4) description of the MI intervention; (5) dose of the MI intervention; (6) description of the comparison group (s); (7) health screening outcome; and (8) major findings and effect sizes.

Each study’s quality was evaluated to consensus by two independent coders. A quality assessment, adapted from previous literature [2022], was used to assess the follow criteria: (1) groups were randomized, (2) groups were similar at baseline (or differences were statistically controlled for in the analyses), (3) eligibility criteria was described, (4) identification of withdrawals and dropouts, (5) intention to treat analysis was implemented; (6) fidelity of the intervention was monitored. Each item was scored (0=no/not reported; 1=yes) and then all items were summed to create a total quality score (range 0–6).

There was significant variability in the quality and methodologies in the articles, and thus a meta-analysis was not performed. Available effect sizes are reported in the results.

3. Results

3.1 Participant Characteristics

The participant demographics from each of the 13 studies are delineated in Table 1.

Table 1.

Participant Demographics

Source Sample size % Non-white % White % Male Age
MI improves health screening, RCT

Outlaw et al. (2010) 188 100% African American 0% 100% Range = 16–24
Mean = 19.79
SD = 2.2
Valanis et al. (2003) 501 Not reported 83% 0% Mean = 59
Manne et al. (2010) 443 1.8% Non-Caucasian 98.2% 37% Mean = 47.6
SD = 13.2
Masson et. al (2013)b 489 28.6%–32% Hispanic
27.5%–31.4% African
American
4.1%–11% Other
35.9%–36.1% 68.2%–68.4% Mean = 44.7–45.0
SD = 9.8–10.3
Fortuna
et. al
(2013)b
1008 Mammography Screening
36.2%–43.4% Non-Hispanic
Black
10.9%–21.1% Other (including
Hispanic)
Mammography
Screening
42.2%–47.7%
Mammography
Screening
0%
Mammography Screening
Aged 40–49 = 46.8%–53.1%
Aged 50–59 = 27.2%–32.0%
Aged 60+ = 15.0%–23.7%
CRC Screening
33.1%–37.6% Non-Hispanic
Black
12.0%–17.3% Other (including
Hispanic)
CRC Screening
48.0%–52.9%
CRC Screening
43.3%–48.1%
CRC Screening
Aged 50–59 = 59.2%–64.6%
Aged 60+ = 35.4%–40.8%
Alemagno et al. (2009) 212 68.6% African American Not reported 63.3% Range = 18–62
Mean = 36

MI improves health screening, single arm

Costanza et al. (2009) 45 Not reported Not reported 0% Aged 45–49 = 24.4%
Aged 50–59 = 28.9%
Aged 60+ = 46.6%
Foley et al. (2005) 105 100% American Indian and
Alaska Natives
0% 67.6% Aged 20–30 = 30.5%
Aged 31–40 = 35.2%
Aged 41–50 = 27.6%
Aged 50+ = 6.7%

MI is not superior to an active control

Taplin et al. (2000) 1765 3.8% Black/African American
0.8% Native American
4.0% Asian/Pacific Islander
2.3% Other
89% 0% Aged 50–59 = 46.3%
Aged 60–69 = 27.6%
Aged 70–79 = 26.1%
Manne et al. (2009) 412 8.6% Non-Caucasian 90.5% 39.8% Mean = 47.9
SD = 9.0

MI does not improve health screening, RCT

Chacko et al. (2010) 376 67% African American
18% Hispanic
4% Other
11% 0% Range = 16–21
Mean = 18.5
SD = 1.4
Menon et al. (2011) 515 72.4% Black
9.9% Other
17.7% 69.7% Mean = 58.1
SD = 7.9
Costanza et al. (2007) a Total sample = 2448

Sample offered MI = 97
Not reported 92% 43% Mean = 61.4
Median = 60
Range = 52–77
a

Statistics reported from entire sample

b

Ranges of percentages across intervention groups

3.2 Study Characteristics

The majority of the studies examined the impact of MI on either cancer screening uptake (N=8) or HIV testing (N=3). The remaining two studies examined the effect of MI on attendance of a hepatitis C screening appointment and on receipt of a screening for sexually transmitted infections. Although all of the studies included in the review implemented some form of MI, the type of MI varied. For example, the dose of the interventions ranged from a one-time 6-minute phone call to a multi session intervention. Furthermore, there was notable variability in the MI interventions’ modes of delivery. Approximately half of the studies implemented the intervention over the telephone, while other studies implemented MI face-to-face or via computer. Two studies did not explicitly report the MI interventions’ modes of delivery. Moreover, the majority of the studies (N=9) delivered MI in combination with another intervention (e.g., print materials, educational presentations).

3.3 Study Quality

The overall quality of the research studies, as defined by our quality scoring assessment, varied amongst the studies. The summed scores ranged from one to six (M=4.38, Median = 5). Of the studies, 11 were randomized clinical trials, 8 had similar groups at baseline (or statistically controlled for differences in the analyses), 12 described eligibility criteria, 6 conducted fidelity monitoring, 8 conducted intent-to-treat analyses, and 12 identified withdrawals and dropouts. The total quality scores are reported in table 2.

Table 2.

Study Outcomes

Source Study
Design
Participants Motivational Interviewing
Intervention
Dose Comparison
Group(s)
Health
Screening
Outcome
Findings Quality
Rating
MI improves health screening, RCT

Outlaw et al. (2010) RCT African
American men
who have sex
with men
Field outreach + MI
Face-to-face MI field
outreach session
One face-to-
face 30-minute
field outreach
session
Traditional field
outreach
Field outreach
session (e.g.,
education about
HIV)
HIV counseling
and testing
Participants in the field
outreach + MI group were
more likely to receive HIV
counseling and testing
(49%) compared to
participants in the
traditional field outreach
group (20%)
(chi squared=17.94;
P=.000)
6
Valanis et
al. (2002)

Valanis et al. (2003)
RCT Women
overdue for a
mammogram
and a pap
smear
Outreach intervention
group
Mailed tailored letter
addressing barriers to
screening

Participants who did not
complete both screening
tests after 6 months also
received an MI telephone
call


Inreach intervention group
Face-to-face MI session
at the time of a primary
care appointment


Combined intervention
group
Both inreach and
outreach interventions
Outreach
One mailed
letter

One 15-minute
telephone call







Inreach
One 20-minute,
face-to-face
session
Control group
Usual Care
Mammogram
and Pap Smear
< 64 years old
Compared to the control
group, participants in the
outreach intervention group
were more likely to receive
both a mammogram and a
pap smear at 14 months
(OR=4.24, 95% CI = 2.22–
8.34) and 24 months (OR
2.53; 95% CI 1.40–4.63)
There were no differences
between the inreach
intervention group and the
control group
There were no differences
between the combined
intervention group and the
control group
> 65 years old
No significant differences
between interventions
groups and the control
group
5
aManne et al. (2010) RCT First degree
relatives of
patients with
melanoma who
were non-
adherent with
skin cancer
prevention
behaviors
Tailored intervention
Three tailored educational
mailings and one tailored
MI counseling call
One telephone
call

Average time =
30.2 minutes
Generic
intervention
Three generic
educational
mailings and a
generic educational
call
Total cutaneous
skin
examination by
a health
provider (TCE),





Skin self-
examination
(SSE)
Compared to the generic
intervention, participants in
the tailored intervention
group were 1.94 times
more likely to have a total
cutaneous skin
examination (OR = 1.94;
95% C.I. 1.39,2.72)

Participants in the tailored
arm were not more likely to
perform skin self-
examination
5
Masson et. al (2013) RCT Men enrolled in
a methadone
maintenance
treatment
program
Intervention group
On site screening for HIV
and hepatitis

MI enhanced education
and counseling

Vaccinations and MI
enhanced case-
management
2 counseling
sessions
(pretest and
posttest)

6 months of
case
management
Control group
Non-MI pretest and
posttest counseling

HIV and Hepatitis
testing

Off-site referral for
vaccine and
hepatitis evaluation
Attendance of
an HCV
evaluation

286 participants
required an
HCV evaluation
on based on
serological
testing
Participants in the
intervention group were
more likely to receive an
HCV evaluation compared
to participants in the
control group (65.1% vs
37.2%, OR = 4.10; 95% CI
= 2.35, 7.17)
5
Fortuna et.
al (2013)
RCT Individuals
overdue for
CRC screening

Women
overdue for
breast cancer
screening
Letter + personal call
A mailed letter

A telephone call that used
MI principles
One telephone
call
Comparison
group
Letter
A mailed letter

Other intervention
groups
Letter + Audiodial
A mailed letter

Up to five
automated
telephone calls

Letter + Audiodial +
prompt
A mailed letter

Up to five
automated calls

Participants and
physicians also
received paper
prompts at a
scheduled
appointment to
discuss cancer
screening
Mammography
or CRC
screening
Compared to a letter alone,
the letter + personal call
group was more effective
at improving screening
rates for breast cancer
(17.8% v 27.5 % AOR 2.2,
95% CI 1.2–4.0) and CRC
(12.2% vs. 21.5%; AOR
2.0, 95% CI 1.1–3.9)

Participants in the letter +
personal call group who
received an MI call
(reached) were more likely
to receive a screening than
those who were unable to
be reached (30.9% v
20.2%, p=0.05)
5
Alemagno et al. (2009) RCT Criminal justice
involved clients
Brief negotiation interview
MI based brief negotiation
interviewing session using
a “talking laptop”
computer
One 20-minute
computerized
intervention
Control group
Written educational
materials on HIV,
STD, TB and
hepatitis
HIV testing Participants in the brief
negotiation interview group
(34.6%) were significantly
more likely to have an HIV
test than participants in the
control group (13.6%)
(chi-square = 8.4, df = 2, p
= .004)
2

MI improves health screening, single arm

Costanza et al. (2009) Single
arm trial
Women
overdue for a
mammogram
≥27months
Computer-assisted
telephone interviewing
with MI
Mailed educational
booklet

Telephone computer-
assisted
tailored
counseling and MI
session

Assistance scheduling a
mammogram
Not reported None Mammogram Of the 45 participants, 26
(57.8%, 95% CI=43.3,
72.0) of the participants
received
a mammogram
2
Foley et al. (2005) Single
arm trial
Substance
users in a
residential
treatment
program
Intervention
Group HIV prevention
educational presentation

Individual MI session
One 60-minute
educational,
group
presentation

One 30-minute
face-to-face
intervention
None HIV testing 78% of participants
(105/134) received HIV
testing
1

MI does not add additional benefit to active control

Taplin et al. (2000) RCT Women who
had not
scheduled a
recommended
mammography
Motivational call
MI telephone call
One telephone
call

Average time =
8.5 minutes
Reminder Postcard
Postcard that
reminded
participants about
the recommended
mammography

Reminder
Telephone Call
Telephone call that
reminded
participants about
the mammography
and assisted in
scheduling the
appointments
Mammogram Participants in the
motivational call group
were more likely to
receive a mammogram
than participants in the
reminder postcard group
(OR=1.8 95% CI 1/5-2.2)

Participants in the
reminder telephone call
group were more likely to
receive a mammogram
than participants in the
reminder postcard group
(OR=1.9, 95% CI 1.5,2.3)

No statistical differences
between the motivational
interviewing telephone
call group and the
reminder call group
6
aManne et al. (2009) RCT Individuals who
were overdue
for a CRC
screening and
had a sibling
diagnosed with
CRC
Tailored print plus
telephone counseling
group
Mailed personal cover
letter and tailored booklet

MI telephone counseling
session

Follow up tailored
newsletter
One telephone
call

Average time =
19 minutes
Generic print group
Mailed cover letter
and generic
pamphlet about
CRC screening

Tailored print group
Mailed personal
cover letter and
tailored booklet
about CRC
screening

One tailored follow
up newsletter
CRC screening Participants in the tailored
print plus telephone
counseling group were
significantly more likely to
be screened than those in
the generic print group
(Wald Chi-Square=4.40; p
=0.036)

Participants in the tailored
print group were more
likely to be screened than
those in the generic print
group (Wald Chi-
Square=6.15; p=0.013)

No significant differences
between the two tailored
intervention groups
5

MI does not improve health screening, RCT

Chacko et al. (2010) RCT Adolescent
women
attending a
community-
based, urban
clinic that
provided free
reproductive
health care
Intervention + standard
care
MI intervention

Clinical care and risk
reduction counseling
One 30–50
minute baseline
session

One 30–50
minute two
week follow up
session

One 15-minute
six month follow
up session
Standard care
Clinical care and
risk reduction
counseling
STI screening No significant differences
between study groups
6
Menon et al. (2011) RCT Primary care
patients who
had no family
history of CRC
and were non-
adherent with
CRC screening
Motivational Interviewing
Telephone-based MI
session
One telephone
call

Average time =
21.2 minutes
Tailored
Counseling
Tailored scripted
telephone
intervention

Control Group
Possible referral for
a CRC screening
CRC screening No significant differences
between the MI group and
the control group
(OR=1.6, 95% C.I.
0.9,2.9)

Participants in the tailored
counseling group were
2.2 times more likely to
receive a CRC screening
than participants in the
control group (OR=2.2;
95% C.I. 1.2, 4.00)
5
Costanza et al. (2007) RCT Primary care
patients who
had not had a
colonoscopy
within the past
10 years
Intervention
Mailed educational
brochure on CRC and
screening

Computer-assisted
counseling telephone call
Participants who were not
planning on getting tested
(N=97) were offered MI
counseling
One telephone
call

Average time of
MI component =
6 minutes
Control group
Usual care
Colonoscopy,
sigmoidoscopy,
or fecal occult
blood testing
There were no statistically
significant differences
between the intervention
and control groups

Of those participants who
were offered MI, 19.5%
changed their screening
intentions (N=19/97)
4

Acronym Key:

RCT = Randomized Control/Clinical Trial

MI = Motivational Interview

CRC = Colorectal Cancer

STD = Sexually Transmitted Disease

TB = Tuberculosis

TCE = Total Cutaneous Skin Examination

SSE = Skin Self-Examination

HCV = Hepatitis C Virus

STI = Sexually Transmitted Infection

Note:

a

Article selected due to the authors’ familiarity with the research.

3.4 Main Effect of MI on Health Screening Uptake

Several studies examined the impact of MI on multiple behaviors, however, only the results relevant to health screening uptake are reported and analyzed in the current paper. Overall, the results regarding the impact of MI on health screening uptake were mixed. Six studies [2328] reported that MI significantly improved health screening uptake, when compared to a control group. Furthermore, two single arm studies [29,30] reported an increase in health screening rates after receiving the MI intervention.

Two studies reported that MI performed significantly better than a minimal comparison group, yet did not provide additional benefit when compared to an active control group. In particular, Taplin and colleagues [31] found that an MI telephone call was more efficacious than a reminder postcard to improve mammography uptake; however, the MI call was no more efficacious than a reminder telephone call. Additionally, Manne and colleagues [32] found that participants who received tailored print materials and an MI counseling telephone call were more likely to receive colorectal cancer screening than participants who received a generic print intervention. The MI intervention, however, did not provide additional benefit to a tailored print material alone.

Finally, three studies (23%) [3335] did not find a significant impact of MI on health screening uptake. The results of the studies are reported in Table 2.

4. Discussion and Conclusion

4.1. Discussion

Although the systematic review produced mixed results, overall MI holds promise for improving health screening uptake. Six of the thirteen studies found that an MI intervention was able to significantly improve health screening uptake, compared to a control group. In particular, these studies found MI efficacious for improving mammography, pap smears, HIV testing/counseling, colorectal cancer screenings, and total cutaneous skin examinations. Five of these six studies had quality ratings of five or greater. These studies support the clinical integration of MI to help improve health screening uptake. Of note, one of the six studies [24] found that individuals who received a tailored intervention which incorporated MI were more likely to have a total cutaneous skin examination but not skin self-examination. Although this study yielded positive findings, the overall results remain mixed.

In addition, two single arm studies found that participants who received an MI intervention had increases in health screening rates, particularly HIV testing and mammography. Due to the studies’ methodologies, there is high potential for bias (quality scores ranged from 1–2) and thus the results should be interpreted cautiously. Although these results are promising, in the absence of randomized clinical trials, we are unable to determine the true impact of MI in these studies.

Furthermore, two high quality studies reported that MI was significantly better than a minimal comparison group, yet did not provide additional benefit when compared to an active control group. These studies provide additional support for the efficacy of MI in this context. However, these results also call into question the necessity and cost effectiveness of implementing MI interventions over more parsimonious treatment options.

Finally, three studies reported that MI did not have a statistically significant impact on health screening uptake. The first study, conducted by Menon and colleagues [34], found that a telephone based MI session did not improve colorectal cancer screening uptake among primary care patients. The odds ratio, however, approached statistical significance (OR=1.6, 95% C.I. 0.9, 2.9). A second study, conducted by Constanza and colleagues [35], examined whether a telephone, computer-assisted counseling intervention could improve colorectal cancer screening rates. Within the intervention group, individuals who reported that they were not planning on getting screened for colorectal cancer were offered MI counseling. The results found that the intervention did not significantly impact colorectal cancer screening rates. Of note, of the 582 participants who received the computer-assisted counseling intervention, only 97 reported that they were not planning on getting screened for colorectal cancer and were thus eligible for MI counseling. Of the 97 participants who were offered MI counseling, 25 (25.7%) refused the additional counseling. Therefore, of the 582 participants in the intervention group, only 97 were even offered MI and only 72 accepted the counseling. Within that group of 97, 19 (19.5%) changed their intentions to get screened. Because MI was not offered to all of the participants, it is difficult to discern the exact impact that MI had on colorectal cancer screening in this context.

A third study, which received a quality rating of six, conducted by Chacko and colleagues [33] found that an MI intervention did not significantly improve screening for sexually transmitted infections among women attending a reproductive clinic. Interestingly, this study was the only study included in the review that implemented MI to improve young adults’/adolescents’ health screening behaviors. Moreover, it was the only study which examined the impact of MI on improving screenings for sexually transmitted infections. Future research is needed to determine whether age and/or outcome moderate the impact of MI intervention on health screening uptake.

Amongst the 13 studies included in systematic review, there was substantial variability in the mode of delivery of MI. Approximately half the studies implemented MI over the telephone, while the other studies conducted the MI in person or via a computer. The mode of delivery of MI did not appear to impact the efficacy of the intervention. These results suggest that more parsimonious and cost-effective methods of delivery (e.g., telephone or computer) may be sufficient to produce behavior change with regard to health screening uptake.

There were several factors that limited our ability to draw definitive conclusions regarding the impact of MI on health screening uptake. Most notably, there was substantial variability in the operational definitions of MI. Some studies provided minimal details regarding the MI intervention while other studies published detailed implementation papers that clearly delineated the MI methods employed in the intervention [e.g., 36]. It is important that future research more clearly defines and describes the MI interventions and how they are being implemented within the study. Such details would allow for more accurate comparisons amongst studies and lay the foundation for future replications studies. Additionally, publishing the details of the intervention provides guidelines for practitioners to disseminate the interventions into standard clinical practice.

Moreover, the majority of the studies included in the systematic review implemented MI in conjunction with other active treatments, such as print materials. In the larger literature, MI is frequently used as an adjunct or a prelude to other empirically supported treatments (e.g., cognitive behavioral therapy, education, self-help manuals) [7]. In fact, it has been argued that combining MI with other treatments may enhance the impact of both interventions on behavioral change [7]. Although combination treatments are often efficacious, with regard to the systematic review, it is difficult to determine the exact impact that MI has on improving health screenings. Future dismantling studies are needed to better understand whether MI serves as a driving component of change in the intervention package. Furthermore, the combination of MI with other treatments poses difficulties in the assessment of treatment fidelity [37].

There are limitations to the systematic review that may have impacted the results. First, there is the potential for publication bias, which could have positively skewed the findings. It is commonly known that null results are often under published [38]. We did not seek the results of unpublished studies, and thus may have missed critical null results. Second, as was pervious discussed, the majority of the studies included in the systematic review implemented MI as an adjunct to a larger treatment. It is possible that studies did not report the MI component of the intervention in the abstract, and thus were missed by our search strategy. In fact, as was previous reported, we were aware of two articles that incorporated MI yet were missed by our search strategy. Third, it is possible that our inclusion criteria were too specific and thus we may have missed relevant articles. In particular, our review search was limited to three databases (PubMed, PsycINFO and CINAHL) and excluded publications that were not in English. Furthermore, only full articles were reviewed and therefore relevant publications (e.g., dissertations, presentations) may have been missed. Future research could conduct a more exhaustive review in order to expand upon the results. Fourth, due to the limited number of articles and the heterogeneity amongst the studies, a formal meta-analysis was not conducted. As this area of research expands, a future study should conduct a meta-analysis to better understand the effect size that MI has on improving health screening uptake.

4.2 Conclusions

Overall, the results of the systematic review were mixed. Of the 13 studies, 6 found MI more efficacious than a control, 2 found MI more efficacious than a weak control yet equivalent to an active control, and 3 found MI was not significantly better than a control. Two single arm studies reported improvements in health screening rates following an MI intervention. While MI shows promise for improving health screening uptake; it may not be the most parsimonious intervention option. Unfortunately, given the mixed results, the wide variability amongst the studies and the limited number of randomized clinical trials, it is difficult to discern the exact impact that MI has on health screening uptake.

4.3 Practical Implications

Future, more detailed, research is needed to better understand the impact that MI can have on health screenings in this context. Furthermore, implementation papers are needed in order to better explain how MI is defined and implemented in each study. This future research would provide further support for the integration of MI into standard clinical practice to improve health screening uptake among adults.

Highlights.

  • 1573 abstracts reviewed to determine the impact of MI on health screenings

  • MI shows promise for improving health screening uptake

  • However, there was wide variability in the methods and quality of the studies

  • Limited ability to draw definitive conclusions about impact of MI in this context

  • More research is needed to determine whether MI can improve health screening uptake

Acknowledgments

Preparation of this manuscript was supported by the National Cancer Institute (K07CA19072601A1) and the American Cancer Society (122931-PF-12-117-01-CPPB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Cancer Society, the National Cancer Institute or the National Institutes of Health.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflicts of Interest

The authors do not have any conflicts of interest.

References

  • 1.Steele CB, Rim SH, Joseph DA, King JB, Seeff LC National Center for Chronic Disease Prevention and Health Promotion, CDC. Colorectal cancer incidence and screening - United States, 2008 and 2010. MMWR Surveill. Summ. 2013;62(Suppl 3):53–60. [PubMed] [Google Scholar]
  • 2.Blackwell D, Lucas J, Clarke T. Summary health statics for U.S. adults: National Health Interview Survey, 2012. 2014;10(260) [PubMed] [Google Scholar]
  • 3.Center for Disease Control and Prevention. Cancer Screening - Unites States, 2010. Morbidity and Mortality Weekly Report (MMWR) 2012;61:41–45. [PubMed] [Google Scholar]
  • 4.Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York: The Guilford Press; 2013. [Google Scholar]
  • 5.Murphy JG, Dennhardt AA, Skidmore JR, Martens MP, McDevitt-Murphy ME. Computerized versus motivational interviewing alcohol interventions: impact on discrepancy, motivation, and drinking. Psychol. Addict. Behav. 2010;24:628–639. doi: 10.1037/a0021347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J. Clin. Psychol. 2009;65:1232–1245. doi: 10.1002/jclp.20638. [DOI] [PubMed] [Google Scholar]
  • 7.Hettema J, Steele J, Miller WR. Motivational interviewing. Annu. Rev. Clin. Psychol. 2005;1:91–111. doi: 10.1146/annurev.clinpsy.1.102803.143833. [DOI] [PubMed] [Google Scholar]
  • 8.Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol. 2006;41:328–335. doi: 10.1093/alcalc/agl016. [DOI] [PubMed] [Google Scholar]
  • 9.Copeland L, McNamara R, Kelson M, Simpson S. Mechanisms of change within motivational interviewing in relation to health behaviors outcomes: a systematic review. Patient Educ. Couns. 2015;98:401–411. doi: 10.1016/j.pec.2014.11.022. [DOI] [PubMed] [Google Scholar]
  • 10.Erickson SJ, Gerstle M, Feldstein SW. Brief interventions and motivational interviewing with children, adolescents, and their parents in pediatric health care settings: a review. Arch. Pediatr. Adolesc. Med. 2005;159:1173–1180. doi: 10.1001/archpedi.159.12.1173. [DOI] [PubMed] [Google Scholar]
  • 11.Martins RK, McNeil DW. Review of Motivational Interviewing in promoting health behaviors. Clin. Psychol. Rev. 2009;29:283–293. doi: 10.1016/j.cpr.2009.02.001. [DOI] [PubMed] [Google Scholar]
  • 12.Lundahl B, Kunz C, Brownell C, Tollefson D, Burke BL. A meta-analysis of motivational interviewing: Twenty-five years of empirical studies. Research on Social Work Practice. 2010;20 [Google Scholar]
  • 13.Resnicow K, DiIorio C, Soet JE, Borrelli B, Hecht J, Ernst D. Motivational Interviewing In Health Promotion: It Sounds Like Something Is Changing. Health Psychology. 2002;21:444. [PubMed] [Google Scholar]
  • 14.Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J. Consult. Clin. Psychol. 2003;71:843–861. doi: 10.1037/0022-006X.71.5.843. [DOI] [PubMed] [Google Scholar]
  • 15.Hettema J, Steele J, Miller WR. Motivational interviewing. Annu. Rev. Clin. Psychol. 2005;1:91–111. doi: 10.1146/annurev.clinpsy.1.102803.143833. [DOI] [PubMed] [Google Scholar]
  • 16.Armstrong MJ, Mottershead TA, Ronksley PE, Sigal RJ, Campbell TS, Hemmelgarn BR. Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes. Rev. 2011;12:709–723. doi: 10.1111/j.1467-789X.2011.00892.x. [DOI] [PubMed] [Google Scholar]
  • 17.Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, Rollnick S. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ. Couns. 2013;93:157–168. doi: 10.1016/j.pec.2013.07.012. [DOI] [PubMed] [Google Scholar]
  • 18.Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22:128. doi: 10.1097/EDE.0b013e3181fe7825. author reply 128. [DOI] [PubMed] [Google Scholar]
  • 19.Moher D, Liberati A, Tetzlaff J, Altman DG PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 2010;8:336–341. doi: 10.1016/j.ijsu.2010.02.007. [DOI] [PubMed] [Google Scholar]
  • 20.Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control. Clin. Trials. 1996;17:1–12. doi: 10.1016/0197-2456(95)00134-4. [DOI] [PubMed] [Google Scholar]
  • 21.Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J. Clin. Epidemiol. 1998;51:1235–1241. doi: 10.1016/s0895-4356(98)00131-0. [DOI] [PubMed] [Google Scholar]
  • 22.Sucala M, Schnur JB, Constantino MJ, Miller SJ, Brackman EH, Montgomery GH. The therapeutic relationship in e-therapy for mental health: a systematic review. J. Med. Internet Res. 2012;14:e110. doi: 10.2196/jmir.2084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Jr, Sorensen JL, Des Jarlais DC, Perlman DC. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am. J. Public Health. 2013;103:e81–e88. doi: 10.2105/AJPH.2013.301458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Manne S, Jacobsen PB, Ming ME, Winkel G, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol. 2010;29:583–593. doi: 10.1037/a0021387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Outlaw AY, Naar-King S, Parsons JT, Green-Jones M, Janisse H, Secord E. Using motivational interviewing in HIV field outreach with young African American men who have sex with men: a randomized clinical trial. Am. J. Public Health. 2010;100(Suppl 1):S146–S151. doi: 10.2105/AJPH.2009.166991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Alemagno SA, Stephens RC, Stephens P, Shaffer-King P, White P. Brief motivational intervention to reduce HIV risk and to increase HIV testing among offenders under community supervision. J. Correct. Health. Care. 2009;15:210–221. doi: 10.1177/1078345809333398. [DOI] [PubMed] [Google Scholar]
  • 27.Valanis B, Whitlock EE, Mullooly J, Vogt T, Smith S, Chen C, Glasgow RE. Screening rarely screened women: time-to-service and 24-month outcomes of tailored interventions. Prev. Med. 2003;37:442–450. doi: 10.1016/s0091-7435(03)00165-8. [DOI] [PubMed] [Google Scholar]
  • 28.Fortuna RJ, Idris A, Winters P, Humiston SG, Scofield S, Hendren S, Ford P, Li SX, Fiscella K. Get screened: a randomized trial of the incremental benefits of reminders, recall, and outreach on cancer screening. J. Gen. Intern. Med. 2014;29:90–97. doi: 10.1007/s11606-013-2586-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Foley K, Duran B, Morris P, Lucero J, Jiang Y, Baxter B, Harrison M, Shurley M, Shorty E, Joe D, Iralu J, Davidson-Stroh L, Foster L, Begay MG, Sonleiter N. Using motivational interviewing to promote HIV testing at an American Indian substance abuse treatment facility. J. Psychoactive Drugs. 2005;37:321–329. doi: 10.1080/02791072.2005.10400526. [DOI] [PubMed] [Google Scholar]
  • 30.Costanza ME, Luckmann R, White MJ, Rosal MC, LaPelle N, Cranos C. Moving mammogram-reluctant women to screening: a pilot study. Ann. Behav. Med. 2009;37:343–349. doi: 10.1007/s12160-009-9107-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Taplin SH, Barlow WE, Ludman E, MacLehos R, Meyer DM, Seger D, Herta D, Chin C, Curry S. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J. Natl. Cancer Inst. 2000;92:233–242. doi: 10.1093/jnci/92.3.233. [DOI] [PubMed] [Google Scholar]
  • 32.Manne SL, Coups EJ, Markowitz A, Meropol NJ, Haller D, Jacobsen PB, Jandorf L, Peterson SK, Lesko S, Pilipshen S, Winkel G. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann. Behav. Med. 2009;37:207–217. doi: 10.1007/s12160-009-9103-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chacko MR, Wiemann CM, Kozinetz CA, von Sternberg K, Velasquez MM, Smith PB, DiClemente R. Efficacy of a motivational behavioral intervention to promote chlamydia and gonorrhea screening in young women: a randomized controlled trial. J. Adolesc. Health. 2010;46:152–161. doi: 10.1016/j.jadohealth.2009.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Menon U, Belue R, Wahab S, Rugen K, Kinney AY, Maramaldi P, Wujcik D, Szalacha LA. A randomized trial comparing the effect of two phone-based interventions on colorectal cancer screening adherence. Ann. Behav. Med. 2011;42:294–303. doi: 10.1007/s12160-011-9291-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Costanza ME, Luckmann R, Stoddard AM, White MJ, Stark JR, Avrunin JS, Rosal MC, Clemow L. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect. Prev. 2007;31:191–198. doi: 10.1016/j.cdp.2007.04.008. [DOI] [PubMed] [Google Scholar]
  • 36.Wahab S, Menon U, Szalacha L. Motivational interviewing and colorectal cancer screening: a peek from the inside out. Patient Educ. Couns. 2008;72:210–217. doi: 10.1016/j.pec.2008.03.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Haddock G, Beardmore R, Earnshaw P, Fitzsimmons M, Nothard S, Butler R, Eisner E, Barrowclough C. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI-CBT fidelity scale (MI-CTS) J. Ment. Health. 2012;21:38–48. doi: 10.3109/09638237.2011.621470. [DOI] [PubMed] [Google Scholar]
  • 38.Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991;337:867–872. doi: 10.1016/0140-6736(91)90201-y. [DOI] [PubMed] [Google Scholar]

RESOURCES